On the morning of March 12, 2019, I was still in a surgical gown and groggy after a colonoscopy when gastroenterologist William B. Evans, III, M.D., walked into the recovery room to deliver news I didn’t quite know what to do with. I still remember his words: “The good news is that I didn’t see…
CAR-T cell therapy takes advantage of the body’s immune system to fight off cancer, much like it does already to kick the common cold and other types of illness. Our bodies don’t always fight off cancer naturally because the cancer cells actually masquerade as healthy cells, and the immune system lets them go on to…
Ultraviolet light, specifically, narrowband UVB light, can reduce skin inflammation, especially as a treatment for eczema and psoriasis. A Louisville-area dermatologist is using this therapy as a treatment for cutaneous T-cell lymphoma, a blood cell cancer that involves the skin. Depending on how much the cutaneous T-cell lymphoma has spread, the thickness of the lesions…
The lump on Lonnie Gardner’s left arm looked innocuous. Maybe an insect bite, he reasoned. For weeks in 2014, the human resources professional went about his business, unconcerned. But the lump got larger and caught the attention of his wife, Megan, who suggested he consult with a dermatologist. More weeks went by. She kept insisting….
Why does a blood cancer start in the skin? Lymphomas are cancers of the immune system, which generally arise in lymph nodes and other lymphatic tissue. The immune system consists of white blood cells, the spleen, lymph nodes and other areas throughout the body. “In many ways, our skin can be considered our largest immune…
When Brenda Montgomery enrolled in a clinical trial at Norton Cancer Institute in February 2016, she hoped the new drug being researched would trounce the cancer she had battled for nine years. She also hoped her efforts would help others. “Hearing you have cancer is like getting hit with a brick, but I’ve been determined…
The U.S. Food and Drug Administration recently approved a new cancer drug that has been available only to patients enrolled by a Norton Cancer Institute physician and one other researcher nationwide. Don A. Stevens, M.D., medical oncologist/hematologist and director of the Hematologic Malignancy Program at Norton Cancer Institute, was one of only two physicians in…
Select an appointment date and time from available spots listed below.